Eckert & Ziegler Strahlen-und Medizintechnik has awarded travel grants to five nuclear medicine scientists from the United States, Japan, Sweden, Switzerland and Austria.
The prize-winners were selected by a jury from the European Association of Nuclear Medicine (EANM) from a total of 400 entries. Work in the fields of cancer and dementia diagnostics received recognition.
The travel grants, which amount to €1,000 ($1,340 U.S.), were presented at the annual congress of the EANM in Munich to:
- M. Samuraki, PhD, Toyama City Hospital in Japan: Prevalence of Reduced Glucose Metabolism or Gray-Matter Concentration in Healthy Apo E _ 4 Carriers: The Ishikawa Brain Imaging Study;
- D. Putzer, PhD, Innsbruck Medical University in Austria: Correlation of 18F-FDG PET/CT and 68Ga-DOTA-TOC PET/CT with tissue markers of poor prognosis in neuroendocrine tumor disease;
- Varrone, PhD, Karolinska Institutet in Sweden: Point Spread Function Reconstruction of High-Resolution Research Tomograph - HRRT - PET-Images Improves In Vivo Neuroreceptor Quantification;
- C.B. Hruska, PhD, Mayo Clinic in Rochester, Minn.: Concordance of Molecular Breast Imaging and Breast MRI findings: A retrospective review; and
- T. Cazaentre, PhD, Hôpitaux Universitaires de Genève in Switzerland: Predictive Factors for Response of Non Hodgkin Lymphomas to Radioimmunotherapy derived from FDG-PET.
Eckert & Ziegler is a provider of isotope component technology for radiation therapy and nuclear medicine.